Get started
Microbix Biosystems Inc.Microbix Biosystems Inc.Microbix Biosystems Inc.

Microbix Biosystems Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

MBXBF chart


Full chart

MBXBF upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪30.64 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
8.3501
Basic EPS (TTM)
0.0271 USD
Net income (FY)
‪−29.06 K‬ USD
Revenue (FY)
‪12.16 M‬ USD
Shares float
‪114.64 M‬
Beta (1Y)
0.57

About MICROBIX BIOSYSTEMS


Sector
Health Technology
Industry
Biotechnology
CEO
Cameron L. Groome
Website
microbix.com
Headquarters
Mississauga
Founded
1988
FIGI
BBG000JRK8S9
Microbix Biosystems, Inc. engages in developing and commercializing proprietary biological and technology solutions for human health and wellbeing. It operates through the Antigens, QAPs and DxTM, and Other segments. The Antigens, QAPs and DxTM segment includes the development, manufacturing and sales of products relating to the medical diagnostics industry. Other deals with the development and commercialization of novel and proprietary products or technologies such as Kinlytic. The company was founded by William J. Gastle in 1988 and is headquartered in Mississauga, Canada.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

MBXBF news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of MBXBF is 0.2288 USD — it has increased by 4.05% in the past 24 hours. Watch Microbix Biosystems Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Microbix Biosystems Inc. stocks are traded under the ticker MBXBF.
MBXBF stock has risen by 4.05% compared to the previous week, the month change is a −11.35% fall, over the last year Microbix Biosystems Inc. has showed a 20.48% increase.
We've gathered analysts' opinions on Microbix Biosystems Inc. future price: according to them, MBXBF price has a max estimate of 0.60 USD and a min estimate of 0.60 USD. Watch MBXBF chart and read a more detailed Microbix Biosystems Inc. stock forecast: see what analysts think of Microbix Biosystems Inc. and suggest that you do with its stocks.
MBXBF reached its all-time high on Jun 27, 2007 with the price of 1.4454 USD, and its all-time low was 0.1231 USD and was reached on Mar 18, 2020. View more price dynamics on MBXBF chart.
See other stocks reaching their highest and lowest prices.
MBXBF stock is 4.77% volatile and has beta coefficient of 0.57. Track Microbix Biosystems Inc. stock price on the chart and check out the list of the most volatile stocks — is Microbix Biosystems Inc. there?
Today Microbix Biosystems Inc. has the market capitalization of ‪30.83 M‬, it has decreased by −4.91% over the last week.
Yes, you can track Microbix Biosystems Inc. financials in yearly and quarterly reports right on TradingView.
Microbix Biosystems Inc. is going to release the next earnings report on Dec 19, 2024. Keep track of upcoming events with our Earnings Calendar.
Microbix Biosystems Inc. revenue for the last quarter amounts to ‪3.70 M‬ USD, despite the estimated figure of ‪4.02 M‬ USD. In the next quarter, revenue is expected to reach ‪4.14 M‬ USD.
MBXBF net income for the last quarter is ‪180.30 K‬ USD, while the quarter before that showed ‪278.84 K‬ USD of net income which accounts for −35.34% change. Track more Microbix Biosystems Inc. financial stats to get the full picture.
No, MBXBF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Microbix Biosystems Inc. EBITDA is ‪2.72 M‬ USD, and current EBITDA margin is −9.56%. See more stats in Microbix Biosystems Inc. financial statements.
Like other stocks, MBXBF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Microbix Biosystems Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Microbix Biosystems Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Microbix Biosystems Inc. stock shows the sell signal. See more of Microbix Biosystems Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.